| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P6179 | Dimensions Publication ID | 1042293073 |
| P356 | DOI | 10.1038/NCB942 |
| P3181 | OpenCitations bibliographic resource ID | 3410927 |
| P698 | PubMed publication ID | 12598905 |
| P50 | author | Yukiko Gotoh | Q89556488 |
| P2093 | author name string | Kunihiro Matsumoto | |
| Shigeaki Kato | |||
| Hiroshi Shibuya | |||
| Takashi Kadowaki | |||
| Yasuhiro Takeuchi | |||
| Toshimasa Yamauchi | |||
| Satoko Ogawa | |||
| Ichiro Takada | |||
| Fumiaki Ohtake | |||
| Junn Yanagisawa | |||
| Miyuki Suzawa | |||
| P2860 | cites work | The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway | Q22009096 |
| TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase | Q24310066 | ||
| TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction | Q24312956 | ||
| IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK | Q24321797 | ||
| Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA | Q27748829 | ||
| TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway | Q28140039 | ||
| Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators | Q28143758 | ||
| Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase | Q28144544 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators | Q28198125 | ||
| An adipogenic cofactor bound by the differentiation domain of PPARgamma | Q28586511 | ||
| Combinatorial roles of the nuclear receptor corepressor in transcription and development | Q28591431 | ||
| Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase | Q29617567 | ||
| The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
| PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance | Q29622888 | ||
| RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells | Q30476196 | ||
| Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase | Q33886831 | ||
| Roles of PPARs in health and disease. | Q33934899 | ||
| Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms | Q34018199 | ||
| The osteoblast: a sophisticated fibroblast under central surveillance | Q34021172 | ||
| Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP). | Q35596558 | ||
| Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma | Q41144553 | ||
| Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells | Q41331286 | ||
| Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta | Q41568089 | ||
| Cloning and characterization of a functional peroxisome proliferator activator receptor-gamma-responsive element in the promoter of the CAP gene | Q42803987 | ||
| Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation | Q73754931 | ||
| Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators | Q74485020 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adipogenesis | Q2824461 |
| P304 | page(s) | 224-30 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Nature Cell Biology | Q1574111 |
| P1476 | title | Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade | |
| P478 | volume | 5 |
| Q40210128 | 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter |
| Q40457879 | A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes |
| Q50466779 | A comparison of the in vitro mineralisation and dentinogenic potential of mesenchymal stem cells derived from adipose tissue, bone marrow and dental pulp. |
| Q52682873 | A delayed proinflammatory response of human preadipocytes to PCB126 is dependent on the aryl hydrocarbon receptor. |
| Q28572633 | A high-fat diet increases IL-1, IL-6, and TNF-α production by increasing NF-κB and attenuating PPAR-γ expression in bone marrow mesenchymal stem cells |
| Q56741581 | A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation |
| Q46418482 | AHSG gene variant is associated with leanness among Swedish men. |
| Q36324040 | Adipogenesis: cellular and molecular aspects. |
| Q42798017 | Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes |
| Q80794574 | Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha |
| Q34931211 | Adipose inflammation, insulin resistance, and cardiovascular disease |
| Q39302706 | Adipose tissue depots and inflammation: effects on plasticity and resident mesenchymal stem cell function |
| Q38286500 | Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: potential impact of dietary fat quality |
| Q36324053 | Adipose tissue: a regulator of inflammation |
| Q41953306 | Amelioration of mitochondrial dysfunction-induced insulin resistance in differentiated 3T3-L1 adipocytes via inhibition of NF-κB pathways |
| Q28208531 | Amyloid β peptide (Aβ42) activates PLC-δ1 promoter through the NF-κB binding site |
| Q35768672 | An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes |
| Q42534662 | Analysis of the Pro- and Anti-Inflammatory Cytokines Secreted by Adult Stem Cells during Differentiation |
| Q33679156 | Antiobesity mechanisms of action of conjugated linoleic acid |
| Q38860543 | Apolipoprotein CIII Induces Monocyte Chemoattractant Protein-1 and Interleukin 6 Expression Via Toll-Like Receptor 2 Pathway in Mouse Adipocytes: Retracted |
| Q35559514 | Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys? |
| Q37096739 | Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells |
| Q84134073 | Beta-catenin protein utilized by Tumour necrosis factor-alpha in porcine preadipocytes to suppress differentiation |
| Q35606415 | Biology and clinical applications of mesenchymal stem cells |
| Q88631820 | Biology of GM3 Ganglioside |
| Q36291257 | Bone marrow-derived mesenchymal stem cells |
| Q37735741 | Bone marrow-derived mesenchymal stem cells and the tumor microenvironment |
| Q36161347 | Brain masculinization requires androgen receptor function |
| Q40449687 | C/EBPalpha activates the transcription of triacylglycerol hydrolase in 3T3-L1 adipocytes. |
| Q43248702 | CDP/cut is an osteoblastic coactivator of the vitamin D receptor (VDR). |
| Q30320094 | CLA isomers inhibit TNFalpha-induced eicosanoid release from human vascular smooth muscle cells via a PPARgamma ligand-like action |
| Q40526717 | Capsaicin inhibits the production of tumor necrosis factor alpha by LPS-stimulated murine macrophages, RAW 264.7: a PPARgamma ligand-like action as a novel mechanism. |
| Q39040821 | Caspase-1 promotes monocyte-macrophage differentiation by repressing PPARγ. |
| Q33828642 | Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration |
| Q39639461 | Challenges in Drug Discovery for Thiazolidinedione Substitute |
| Q40505444 | Classical and alternative NF-κB signaling cooperate in regulating adipocyte differentiation and function. |
| Q50101859 | ComPPARtmentalizing NF-kappaB in the gut. |
| Q50101913 | Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. |
| Q34312856 | Conjugated linoleic acid induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines |
| Q34147790 | Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. |
| Q37086152 | Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol |
| Q53012519 | Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3. |
| Q34625258 | Curcumin and obesity: evidence and mechanisms |
| Q37984124 | Curcumin molecular targets in obesity and obesity-related cancers |
| Q44735929 | Cytokines regulate fibroblast-like synovial cell differentiation to adipocyte-like cells |
| Q81526916 | Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure |
| Q30241888 | Dendritic cells and adipose tissue |
| Q43141500 | Development of a rapid culture method to induce adipocyte differentiation of human bone marrow-derived mesenchymal stem cells |
| Q36744091 | Diacylglycerol kinase inhibitor R59022 attenuates conjugated linoleic acid-mediated inflammation in human adipocytes |
| Q33393459 | Differential RelA- and RelB-dependent gene transcription in LTbetaR-stimulated mouse embryonic fibroblasts |
| Q40119020 | Differential ability of a thiazolidinedione PPARgamma agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells |
| Q31135521 | Discovering small molecules that inhibit adipogenesis and promote osteoblastogenesis: unique screening and Oncostatin M-like activity |
| Q40523512 | Distinct roles of BMP receptors Type IA and IB in osteo-/chondrogenic differentiation in mesenchymal progenitors (C3H10T1/2). |
| Q37981459 | Do microRNAs regulate bone marrow stem cell niche physiology? |
| Q33897689 | Double PHD fingers protein DPF2 recognizes acetylated histones and suppresses the function of estrogen-related receptor alpha through histone deacetylase 1 |
| Q34092765 | Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate |
| Q28593674 | Dual roles for the Notch target gene Hes-1 in the differentiation of 3T3-L1 preadipocytes |
| Q42804383 | Effect of Wnt-1 inducible signaling pathway protein-2 (WISP-2/CCN5), a downstream protein of Wnt signaling, on adipocyte differentiation |
| Q81160123 | Effects of chronic exercise on cytokine production in white adipose tissue and skeletal muscle of rats |
| Q42799080 | Effects of phorbol ester-sensitive PKC (c/nPKC) activation on the production of adiponectin in 3T3-L1 adipocytes |
| Q50470597 | Effects of substrate stiffness on adipogenic and osteogenic differentiation of human mesenchymal stem cells. |
| Q37116246 | Emerging role of adipose tissue hypoxia in obesity and insulin resistance |
| Q55517488 | Eosinophils support adipocyte maturation and promote glucose tolerance in obesity. |
| Q34679499 | Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts |
| Q36957982 | Flexible and dynamic organization of bone marrow stromal compartment |
| Q42597088 | Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. |
| Q46327329 | Gene expression profile of the bone microenvironment in human fragility fracture bone |
| Q36267948 | Genes involved in obesity: Adipocytes, brain and microflora |
| Q33493427 | Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program |
| Q38328121 | Genome-wide repression of NF-κB target genes by transcription factor MIBP1 and its modulation by O-linked β-N-acetylglucosamine (O-GlcNAc) transferase |
| Q79976898 | HDAC activity is required for p65/RelA-dependent repression of PPARdelta-mediated transactivation in human keratinocytes |
| Q35640258 | HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies |
| Q34346778 | Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect |
| Q45770808 | High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway |
| Q40538409 | IL-1 and LPS but not IL-6 inhibit differentiation and downregulate PPAR gamma in brown adipocytes. |
| Q50942222 | Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. |
| Q38317297 | Identification of novel PPARgamma target genes in primary human adipocytes |
| Q40168723 | Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy. |
| Q35417015 | Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy |
| Q112292512 | In situ transplantation of adipose-derived stem cells via photoactivation improves glucose metabolism in obese mice |
| Q50622058 | In vivo gene transfer of PPAR gamma is insufficient to induce adipogenesis in skeletal muscle. |
| Q44522392 | Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels |
| Q38333467 | Inflammation inhibits GPR81 expression in adipose tissue |
| Q37906726 | Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals |
| Q44228560 | Inflammatory environment induces gingival tissue-specific mesenchymal stem cells to differentiate towards a pro-fibrotic phenotype |
| Q36447976 | Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP |
| Q36838847 | Insulin signalling mechanisms for triacylglycerol storage |
| Q46703969 | Interaction between NF-κB signaling and Notch signaling in gliogenesis of mouse mesencephalic neural crest cells. |
| Q33768617 | Interactive changes between macrophages and adipocytes |
| Q34318738 | Interleukin-1 beta: a potential link between stress and the development of visceral obesity |
| Q46872864 | Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. |
| Q34558529 | Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability |
| Q36375063 | Interplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration |
| Q38341516 | Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knock-out mice is associated with differences in patterns of gene expression |
| Q35631488 | Involvement of neuronal TGF-β activated kinase 1 in the development of tolerance to morphine-induced antinociception in rat spinal cord |
| Q23912824 | Is NF-kappaB a culprit in type 2 diabetes? |
| Q35196534 | JNK inhibition by SP600125 attenuates trans-10, cis-12 conjugated linoleic acid-mediated regulation of inflammatory and lipogenic gene expression |
| Q36747280 | Lessons from musculoskeletal stem cell research: the key to successful regenerative medicine development |
| Q42819277 | Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF-κB pathway and downregulation of AMPK expression |
| Q36782381 | Local adipose tissue depots as cardiovascular risk factors |
| Q37257195 | Lymphotoxin-β receptor signaling through NF-κB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells |
| Q51109464 | Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. |
| Q42491649 | Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. |
| Q34331776 | Mechanisms of insulin resistance in obesity |
| Q36848096 | Mechanisms of transcriptional repression by 1,25(OH)2 vitamin D. |
| Q40053820 | Membrane proteomic analysis of human mesenchymal stromal cells during adipogenesis |
| Q39324809 | Mesenchimal stem cells: a possible role in the pathogenesis and treatment of spondyloarthritis |
| Q55314890 | Mesenchymal Stem Cell Transplantation for Tissue Repair. |
| Q80226827 | Mesenchymal stem cells |
| Q37592909 | Mesenchymal stem cells for craniofacial tissue regeneration: designing hydrogel delivery vehicles |
| Q37156192 | Mesenchymal stem cells for tissue engineering and regenerative medicine |
| Q36933699 | Mesenchymal stem cells in rheumatology: a regenerative approach to joint repair |
| Q35686355 | Mesenchymal stem cells: clinical applications and biological characterization. |
| Q37370552 | Mesenchymal stromal cells in rheumatoid arthritis: biological properties and clinical applications. |
| Q39224695 | MiR-143 is not essential for adipose development as revealed by in vivo antisense targeting |
| Q35008901 | MiRNA-181a regulates adipogenesis by targeting tumor necrosis factor-α (TNF-α) in the porcine model |
| Q38337327 | Modulation of peroxisome proliferator-activated receptor gamma (PPAR γ) by conjugated fatty acid in obesity and inflammatory bowel disease. |
| Q38509245 | Molecular Mechanisms of PPAR-γ Governing MSC Osteogenic and Adipogenic Differentiation. |
| Q48312086 | Molecular characterisation of tumour necrosis factor alpha and its potential connection with lipoprotein lipase and peroxisome proliferator-activated receptors in blunt snout bream (Megalobrama amblycephala). |
| Q83737442 | Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies |
| Q36294297 | Molecular targets related to inflammation and insulin resistance and potential interventions |
| Q34695969 | Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2. |
| Q40296221 | NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity |
| Q34744211 | NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. |
| Q37777775 | NF-κB inducing kinase: A key regulator in the immune system and in cancer |
| Q57420154 | NF-κB is important for TNF-α-induced lipolysis in human adipocytes |
| Q59607686 | Network analysis of adipose tissue gene expression highlights altered metabolic and regulatory transcriptomic activity in high-fat-diet-fed IL-1RI knockout mice |
| Q35786209 | New insights into inhibitors of adipogenesis |
| Q37858464 | New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases |
| Q38272011 | Nicotinic acid regulates glucose and lipid metabolism through lipid independent pathways |
| Q37073554 | Nuclear factor-κB modulates osteogenesis of periodontal ligament stem cells through competition with β-catenin signaling in inflammatory microenvironments. |
| Q36051617 | Nuclear receptors as targets for drug development: crosstalk between peroxisome proliferator-activated receptor gamma and cytokines in bone marrow-derived mesenchymal stem cells |
| Q42834658 | Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways |
| Q38441017 | Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review |
| Q53310070 | Overexpressed human heme Oxygenase-1 decreases adipogenesis in pigs and porcine adipose-derived stem cells. |
| Q112722648 | Oxidant therapy improves adipogenic differentiation of adipose-derived stem cells in human wound healing |
| Q36076299 | PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation |
| Q34007810 | PKCzeta-regulated inflammation in the nonhematopoietic compartment is critical for obesity-induced glucose intolerance |
| Q42612084 | PPAR-gamma Signaling Crosstalk in Mesenchymal Stem Cells |
| Q45965487 | PPARgamma Pro12Ala polymorphism in HIV-1-infected patients with HAART-related lipodystrophy. |
| Q24633440 | PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 |
| Q41828567 | PPARs and Adipose Cell Plasticity |
| Q35235680 | Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner |
| Q83204970 | Peroxisome proliferator-activated receptor alpha, delta, gamma1 and gamma2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands |
| Q46662311 | Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway |
| Q44710999 | Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells |
| Q47684295 | Peroxisome proliferator-activated receptor gamma polymorphism is related to peak bone mass: the JPOS study |
| Q40499667 | Peroxisome proliferator-activated receptor gamma-dependent and -independent growth inhibition of gastrointestinal tumour cells |
| Q37959656 | Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis |
| Q38192745 | Physiologic versus diabetogenic effects of interleukin-1: a question of weight |
| Q80010792 | Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes |
| Q47667700 | Prenatal Exposure to Endocrine Disruptors and Reprogramming of Adipogenesis: An Early-Life Risk Factor for Childhood Obesity |
| Q53602578 | Preservation of high-fat diet-induced femoral trabecular bone loss through genetic target of TNF-α. |
| Q39068615 | Pro-Inflammation Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders |
| Q57815847 | Pro-inflammatory cytokines: The link between obesity and osteoarthritis |
| Q35865862 | Progeroid syndrome as a model for impaired bone formation in senile osteoporosis |
| Q54499514 | Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. |
| Q42987178 | Prostaglandin F(2alpha) suppresses early phase of adipogenesis, but is not associated with osteoblastogenesis in mouse mesenchymal stem cells |
| Q53294010 | Proteomics and transcriptomics investigation on longissimus muscles in Large White and Casertana pig breeds. |
| Q82399353 | Radiation hybrid mapping of seven bovine genes encoding transcription factors involved in adipogenesis |
| Q38131118 | Reconciling the effects of inflammatory cytokines on mesenchymal cell osteogenic differentiation |
| Q37226915 | Regulation of PPARgamma function by TNF-alpha |
| Q37770377 | Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction |
| Q35786203 | Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines |
| Q27028193 | Regulation of stem cell differentiation in adipose tissue by chronic inflammation |
| Q47386774 | Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue |
| Q39270866 | Retinoic acid regulates commitment of undifferentiated mesenchymal stem cells into osteoblasts and adipocytes |
| Q85892558 | Retraction: Cytokines suppress adipogenesis and PPAR-γ function through the TAK1/TAB1/NIK cascade |
| Q37611364 | Role of NF-kappa B in the pathogenesis of diabetes and its associated complications |
| Q42467739 | Role of transforming growth factor-activated kinase-1 on tumor necrosis factor-α actions in human adipose tissue-derived stromal cells |
| Q79901709 | Rosiglitazone antagonizes vascular endothelial growth factor signaling and nuclear factor of activated T cells activation in cardiac valve endothelium |
| Q39622012 | Rosiglitazone attenuates the metalloprotease/anti-metalloprotease imbalance in emphysema induced by cigarette smoke: involvement of extracellular signal-regulated kinase and NFκB signaling |
| Q48262575 | Scaffold-free generation of uniform adipose spheroids for metabolism research and drug discovery. |
| Q47793450 | Sequestration of thermogenic transcription factors in the cytoplasm during development of brown adipose tissue |
| Q37159360 | Signal transduction and transcriptional regulation during mesenchymal cell differentiation. |
| Q42802584 | Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation |
| Q24633409 | Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet |
| Q37070707 | Stem cells: an overview |
| Q38324142 | Stimulation of resorption in cultured mouse calvarial bones by thiazolidinediones |
| Q46866093 | Stress-induced cytokine responses and central adiposity in young women |
| Q24301453 | Structure of the SCAN domain from the tumor suppressor protein MZF1 |
| Q34656434 | Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts |
| Q40624072 | Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta |
| Q24297399 | TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation |
| Q35006572 | TNF-alpha and adipocyte biology |
| Q54389261 | TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-κB and PPAR-γ. |
| Q85014609 | TNF-α stimulates alkaline phosphatase and mineralization through PPARγ inhibition in human osteoblasts |
| Q81268702 | TRRAP as a hepatic coactivator of LXR and FXR function |
| Q35129349 | Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals |
| Q42814401 | Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes |
| Q83165111 | Tensile strain as a regulator of mesenchymal stem cell osteogenesis |
| Q28078585 | The Bone Marrow-Derived Stromal Cells: Commitment and Regulation of Adipogenesis |
| Q47267239 | The Effects of Hyperacute Serum on Adipogenesis and Cell Proliferation of Mesenchymal Stromal Cells |
| Q92012185 | The Influence of Light on Reactive Oxygen Species and NF-кB in Disease Progression |
| Q28288503 | The NF-kappaB regulatory network |
| Q40032475 | The adipogenic acetyltransferase Tip60 targets activation function 1 of peroxisome proliferator-activated receptor gamma |
| Q39661936 | The anti-adipogenic effect of macrophage-conditioned medium requires the IKKβ/NF-κB pathway. |
| Q37641459 | The autocrine and paracrine roles of adipokines. |
| Q37430626 | The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response |
| Q42818803 | The effects of NOD activation on adipocyte differentiation |
| Q42806255 | The effects of hydroxycinnamic acid derivatives on adiponectin secretion |
| Q35571994 | The function of nuclear receptors in bone tissues |
| Q33994438 | The many facets of PPARgamma: novel insights for the skeleton |
| Q34208083 | The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation |
| Q35948133 | The pituitary function of androgen receptor constitutes a glucocorticoid production circuit |
| Q36268038 | The role of recipient T cells in mesenchymal stem cell-based tissue regeneration |
| Q24628865 | The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-β (TGFβ) signaling |
| Q51230354 | The use of small interfering RNAs to inhibit adipocyte differentiation in human preadipocytes and fetal-femur-derived mesenchymal cells. |
| Q46265499 | Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance |
| Q42827019 | Tissue inhibitor of metalloproteases-4 (TIMP-4) modulates adipocyte differentiation in vitro |
| Q39990710 | Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages |
| Q36193738 | Towards a Systematic Screening Tool for Quality Assurance and Semiautomatic Fraud Detection for Images in the Life Sciences |
| Q36544924 | Toxic metabolic syndrome associated with HAART. |
| Q42141293 | Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes |
| Q42826754 | Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation. |
| Q37650762 | Transcriptional and post-translational regulation of adiponectin |
| Q35141043 | Transcriptome analysis of hen preadipocytes treated with an adipogenic cocktail (DMIOA) with or without 20(S)-hydroxylcholesterol |
| Q28219857 | Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes |
| Q40610380 | Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells |
| Q81480642 | Tumor necrosis factor-alpha stimulates HIV-1 production in primary culture of human adipocytes |
| Q39247138 | Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway. |
| Q42027895 | Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. |
| Q42798829 | Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response |
| Q33717545 | Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure |
| Q34336984 | Use of small interfering ribonucleic acids to inhibit the adipogenic effect of alcohol on human bone marrow-derived mesenchymal cells |
| Q42805768 | Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity |
| Q40079327 | Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene |
| Q29540785 | Winning a Won Game: Caffeine Panacea for Obesity Syndemic |
| Q37542905 | Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis |
| Q28568441 | Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis |
| Q44046208 | Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance in primary cultures of human adipocytes |
| Q34575607 | Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment. |
| Q80259243 | [Diabetes and the metabolic syndrome] |
| Q42505862 | dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors |
| Q94667781 | β-arrestin 2 quenches TLR signaling to facilitate the immune evasion of EPEC |
| Q83395250 | γ-Oryzanol recovers mouse hypoadiponectinemia induced by animal fat ingestion |
Search more.